5-FU/leucovorin, irinotecan, oxaliplatin (FOLFIRINOX) induction followed by chemoXRT in borderline resectable pancreatic cancer.
Jordan Kharofa
No relevant relationships to disclose
Tracy R. Kelly
No relevant relationships to disclose
Paul S. Ritch
No relevant relationships to disclose
Ben George
No relevant relationships to disclose
Lauren Allison Wiebe
No relevant relationships to disclose
James P. Thomas
No relevant relationships to disclose
Kathleen K. Christians
No relevant relationships to disclose
Douglas B. Evans
No relevant relationships to disclose
Beth Erickson
No relevant relationships to disclose